BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24648112)

  • 1. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
    Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
    J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
    Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
    Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
    Guo D; Wang C; Wang Q; Qiao Z; Tang H
    Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 regulates MMP-10 expression via JAK2/STAT3 signaling pathway in a human lung adenocarcinoma cell line.
    Zhang X; Yin P; DI D; Luo G; Zheng L; Wei J; Zhang J; Shi Y; Zhang J; Xu N
    Anticancer Res; 2009 Nov; 29(11):4497-501. PubMed ID: 20032397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
    Beckles DL; Mascareno E; Siddiqui MA
    Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The JAK2/STAT3 signal pathway regulates the expression of genes related to skeletal muscle development and energy metabolism in mice and mouse skeletal muscle cells.
    Liu J; Jing X; Gan L; Sun C
    Biosci Biotechnol Biochem; 2012; 76(10):1866-70. PubMed ID: 23047097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
    DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD
    J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
    Fendrich V; Sparn M; Lauth M; Knoop R; Plassmeier L; Bartsch DK; Waldmann J
    Pancreatology; 2013; 13(5):502-7. PubMed ID: 24075515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.
    Wörmann SM; Song L; Ai J; Diakopoulos KN; Kurkowski MU; Görgülü K; Ruess D; Campbell A; Doglioni C; Jodrell D; Neesse A; Demir IE; Karpathaki AP; Barenboim M; Hagemann T; Rose-John S; Sansom O; Schmid RM; Protti MP; Lesina M; Algül H
    Gastroenterology; 2016 Jul; 151(1):180-193.e12. PubMed ID: 27003603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 attenuates trimethyltin-induced cognitive dysfunction via activation of JAK2/STAT3, M1 mAChR and ERK signaling network.
    Kim BK; Tran HY; Shin EJ; Lee C; Chung YH; Jeong JH; Bach JH; Kim WK; Park DH; Saito K; Nabeshima T; Kim HC
    Cell Signal; 2013 Jun; 25(6):1348-60. PubMed ID: 23499905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Jak/STAT signaling ameliorates mice experimental nephrotic syndrome.
    Li R; Yang N; Zhang L; Huang Y; Zhang R; Wang F; Luo M; Liang Y; Yu X
    Am J Nephrol; 2007; 27(6):580-9. PubMed ID: 17823504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro.
    Huang C; Cao J; Huang KJ; Zhang F; Jiang T; Zhu L; Qiu ZJ
    Cancer Sci; 2006 Dec; 97(12):1417-23. PubMed ID: 17054436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired JAK2-induced activation of STAT3 in failing human myocytes.
    Cambi GE; Lucchese G; Djeokeng MM; Modesti A; Fiaschi T; Faggian G; Sani G; Modesti PA
    Mol Biosyst; 2012 Sep; 8(9):2351-9. PubMed ID: 22735740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer.
    Mace TA; Shakya R; Elnaggar O; Wilson K; Komar HM; Yang J; Pitarresi JR; Young GS; Ostrowski MC; Ludwig T; Bekaii-Saab T; Bloomston M; Lesinski GB
    Oncotarget; 2015 Dec; 6(42):44509-22. PubMed ID: 26575024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
    Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
    Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.